HCP (HCP) : The consensus on HCP (HCP) based on 10 analyst recommendation on the company stock is 3.53, which is interpreted as a Sell recommendation. Zacks Investment Research has issued a rank of 2 which endorses a Buy on the stock. However, 1 analyst believes that the stock is a Buy, which can produce decent returns in the future. 5 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating. 3 analyst sees the stock overvalued at current levels and advises a Strong Sell on the stock. 1 analyst also believes that the downside risk to the stock is higher and suggests a Sell on HCP (HCP).
HCP (HCP) : Average target price received by HCP (HCP) is $35 with an expected standard deviation of $4.34. The most aggressive target on the stock is $43, whereas the most downbeat target is $32. 6 financial analysts are currently covering the stock.
Shares of HCP, Inc. rose by 1.4% in the last five trading days and 3.31% for the last 4 weeks. HCP, Inc. is up 24% in the last 3-month period. Year-to-Date the stock performance stands at 9.04%. HCP (NYSE:HCP): stock turned positive on Tuesday. Though the stock opened at $39.63, the bulls momentum made the stock top out at $39.99 level for the day. The stock recorded a low of $39.47 and closed the trading day at $39.78, in the green by 0.91%. The total traded volume for the day was 2,403,030. The stock had closed at $39.42 in the previous days trading.
HCP, Inc. (HCP) is a real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital. Its portfolio includes owned portfolio, unconsolidated joint ventures, and developments and redevelopments. Its owned portfolio includes around 1,040 properties under lease and 68 operating properties. It has interests in unconsolidated joint ventures representing around 88 properties in its senior housing, life science and medical office segments. It has assets under development, redevelopment and land held for future development in life science and medical office segments. The properties owned by it in medical office and senior housing segments, which are under development or redevelopment include Pacific Corporate Park, Memorial Hermann, Sky Ridge, Bayfront, Folsom and Deer Park.